The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
The Phase III international clinical trial will recruit a total of 5,000 people across countries in Europe and the United States to assess the ... Nov 21
-Advertisements-